UBS ASSET MANAGEMENT AMERICAS INC - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 144 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$118,0270.0%84,9120.0%0.00%
Q1 2023$118,027
-30.2%
84,9120.0%0.00%
Q4 2022$168,975
-99.9%
84,9120.0%0.00%
Q3 2022$171,523,000
-45.5%
84,912
-14.2%
0.00%
Q2 2022$314,773,000
-23.7%
98,9850.0%0.00%
Q1 2022$412,767,000
-12.9%
98,9850.0%0.00%
Q4 2021$474,139,000
-10.3%
98,9850.0%0.00%
Q3 2021$528,580,000
+4.3%
98,9850.0%0.00%
Q2 2021$506,804,000
-13.4%
98,985
+13.8%
0.00%
Q1 2021$585,166,000
+42.9%
86,949
-3.0%
0.00%
Q4 2020$409,495,000
-7.8%
89,605
-21.8%
0.00%
Q3 2020$444,314,000
-18.5%
114,5140.0%0.00%
Q2 2020$545,087,000
+34.2%
114,514
-1.9%
0.00%
Q1 2020$406,213,000
-1.5%
116,728
+36.5%
0.00%
Q4 2019$412,289,000
+33.5%
85,537
-19.7%
0.00%
Q3 2019$308,781,000
-52.5%
106,476
+17.4%
0.00%
Q2 2019$650,368,000
-20.4%
90,707
+57.3%
0.00%
-100.0%
Q1 2019$817,239,000
+63.9%
57,674
+56.5%
0.00%
Q4 2018$498,540,000
-55.4%
36,847
-26.8%
0.00%
-100.0%
Q3 2018$1,117,511,000
+125.5%
50,361
+66.8%
0.00%
Q2 2018$495,549,00030,1980.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$83,503,0007.34%
Eversept Partners, LP 2,656,208$10,306,0872.29%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$62,908,0001.13%
Prosight Management, LP 512,659$1,989,0000.95%
THB ASSET MANAGEMENT 833,104$3,232,0000.90%
GLOBEFLEX CAPITAL L P 251,696$977,0000.26%
XTX MARKETS LLC 10,243$40,0000.19%
HUSSMAN STRATEGIC ADVISORS, INC. 102,000$396,0000.10%
PA Capital LLC 33,874$132,0000.09%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 60,900$236,0000.07%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders